United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85509-1920_3a116427-c428-c3bc-e063-6294a90ac539
- Product NDC
- 85509-1920
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- PHOENIX RX LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20190304
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85509-1920-3) · 85509-1920-3
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85509-1920-6) · 85509-1920-6
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (85509-1920-9) · 85509-1920-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →